HU9502968D0 - 4-aryl-4-hydroxy-tetrahydropyrans and 3-aryl-3-hydroxy-tetrahydrofurans as 5-lipoxygenase inhibitors - Google Patents
4-aryl-4-hydroxy-tetrahydropyrans and 3-aryl-3-hydroxy-tetrahydrofurans as 5-lipoxygenase inhibitorsInfo
- Publication number
- HU9502968D0 HU9502968D0 HU9502968A HU9502968A HU9502968D0 HU 9502968 D0 HU9502968 D0 HU 9502968D0 HU 9502968 A HU9502968 A HU 9502968A HU 9502968 A HU9502968 A HU 9502968A HU 9502968 D0 HU9502968 D0 HU 9502968D0
- Authority
- HU
- Hungary
- Prior art keywords
- aryl
- hydroxy
- tetrahydropyrans
- tetrahydrofurans
- lipoxygenase inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP93401120 | 1993-04-29 | ||
| EP93401991 | 1993-08-02 | ||
| EP94400190 | 1994-01-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU9502968D0 true HU9502968D0 (en) | 1995-12-28 |
Family
ID=27235558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9502968A HU9502968D0 (en) | 1993-04-29 | 1994-04-25 | 4-aryl-4-hydroxy-tetrahydropyrans and 3-aryl-3-hydroxy-tetrahydrofurans as 5-lipoxygenase inhibitors |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US5478842A (hu) |
| EP (1) | EP0623614B1 (hu) |
| JP (1) | JP3553127B2 (hu) |
| KR (1) | KR100358464B1 (hu) |
| CN (1) | CN1052002C (hu) |
| AP (1) | AP9400632A0 (hu) |
| AT (1) | ATE163417T1 (hu) |
| AU (1) | AU681886B2 (hu) |
| CA (1) | CA2121199C (hu) |
| CZ (1) | CZ280695A3 (hu) |
| DE (1) | DE69408593T2 (hu) |
| DK (1) | DK0623614T3 (hu) |
| ES (1) | ES2112483T3 (hu) |
| FI (2) | FI109123B (hu) |
| GB (1) | GB9408001D0 (hu) |
| HK (1) | HK1004777A1 (hu) |
| HU (1) | HU9502968D0 (hu) |
| IL (1) | IL109254A (hu) |
| NO (1) | NO309191B1 (hu) |
| NZ (1) | NZ266139A (hu) |
| PL (1) | PL311300A1 (hu) |
| SK (1) | SK134995A3 (hu) |
| TW (1) | TW252978B (hu) |
| WO (1) | WO1994025453A1 (hu) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3990972B2 (ja) * | 2001-11-20 | 2007-10-17 | 有限会社 キック | 血管再狭窄防止薬及び該防止薬がコーティングされた血管内埋め込み器具 |
| SE0104274D0 (sv) * | 2001-12-17 | 2001-12-17 | Astrazeneca Ab | Novel process |
| DE102004002557A1 (de) * | 2004-01-17 | 2005-08-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen |
| US8158362B2 (en) | 2005-03-30 | 2012-04-17 | Decode Genetics Ehf. | Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype |
| JP2009523820A (ja) | 2006-01-23 | 2009-06-25 | アミラ ファーマシューティカルス，インコーポレーテッド | ５−リポキシゲナーゼの三環系抑制剤 |
| JP2010511632A (ja) | 2006-11-30 | 2010-04-15 | アミラ ファーマシューティカルス，インコーポレーテッド | ５−リポキシゲナーゼ活性化タンパク質インヒビターおよび一酸化窒素モジュレーターを含んでいる組成物および治療法 |
| US10793515B2 (en) * | 2008-03-19 | 2020-10-06 | Aurimmed Pharma, Inc. | Compounds advantageous in the treatment of central nervous system diseases and disorders |
| NZ624963A (en) | 2009-04-29 | 2016-07-29 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| WO2015120038A1 (en) | 2014-02-04 | 2015-08-13 | Bioscience Pharma Partners, Llc | Use of flap inhibitors to reduce neuroinflammation mediated injury in the central nervous system |
| ME03663B (me) | 2015-05-04 | 2020-07-20 | Astrazeneca Ab | Derivati rirazola korisni kao inhibitori proteina koji aktivira 5-lipoksigenazu (flap) |
| JP7041146B2 (ja) | 2016-10-28 | 2022-03-23 | アストラゼネカ・アクチエボラーグ | （１Ｒ，２Ｒ）－２－［４－（３－メチル－１Ｈ－ピラゾール－５－イル）ベンゾイル］－Ｎ－（４－オキソ－４，５，６，７－テトラヒドロピラゾロ［１，５－ａ］ピラジン－３－イル）シクロヘキサンカルボキサミド |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4794188A (en) * | 1982-12-01 | 1988-12-27 | Usv Pharmaceutical Corporation | Certain unsymmetrical quinolinyl ethers having anti-inflammatory and anti-allergic activity |
| US4567184A (en) * | 1982-12-01 | 1986-01-28 | Usv Pharmaceutical Corporation | Certain aryl or hetero-aryl derivatives of 1-hydroxy-pentane or 1-hydroxy-hexane which are useful for treating inflammation and allergies |
| US4625034A (en) * | 1985-02-04 | 1986-11-25 | Usv Pharmaceutical Corp. | 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives |
| US4839369A (en) * | 1985-04-16 | 1989-06-13 | Rorer Pharmaceutical Corporation | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
| US4631287A (en) * | 1985-04-16 | 1986-12-23 | Usv Pharmaceutical Corp. | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
| US4725619A (en) * | 1985-04-16 | 1988-02-16 | Usv Pharmaceutical Corporation | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
| US4728668A (en) * | 1985-04-16 | 1988-03-01 | Usv Pharmaceutical Corporation | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
| US4868193A (en) * | 1986-09-24 | 1989-09-19 | Rorer Pharmaceutical Corporation | Styryl tetrazoles and anti-allergic use thereof |
| GB8926981D0 (en) * | 1988-12-23 | 1990-01-17 | Ici Plc | Heterocyclic derivatives |
| US5234950A (en) * | 1988-12-23 | 1993-08-10 | Imperial Chemical Industries Plc | Tetrahydrofuran derivatives |
| US5202326A (en) * | 1989-02-28 | 1993-04-13 | Imperial Chemical Industries Plc | Heterocyclic ethers |
| IE70521B1 (en) * | 1989-02-28 | 1996-12-11 | Zeneca Pharma Sa | Heterocycles with inhibitory activity of 5-lipoxygenase |
| US5236919A (en) * | 1989-02-28 | 1993-08-17 | Imperial Chemical Industries Plc | Quinoxalinyl derivatives suitable for use in leukotriene mediated disease |
| US5134148A (en) * | 1989-02-28 | 1992-07-28 | Imperial Chemical Industries Plc | Heterocycles for use as inhibitors of leukotrienes |
| IE64358B1 (en) * | 1989-07-18 | 1995-07-26 | Ici Plc | Diaryl ether heterocycles |
| GB9018134D0 (en) * | 1989-09-29 | 1990-10-03 | Ici Plc | Heterocyclic derivatives |
| US5088927A (en) * | 1990-06-18 | 1992-02-18 | Lee Howard G | Radio opaque plastics and process of making |
| AU637500B2 (en) * | 1990-06-21 | 1993-05-27 | Zeneca Limited | Bicyclic heterocyclic compounds |
| IE911853A1 (en) * | 1990-06-21 | 1992-01-01 | Ici Plc | Heterocyclene derivatives |
| GB9113137D0 (en) * | 1990-07-13 | 1991-08-07 | Ici Plc | Thioxo heterocycles |
| US5272173A (en) * | 1990-11-28 | 1993-12-21 | Imperial Chemical Industries Plc | 5-lipoxygenase inhibitors |
| IE913866A1 (en) * | 1990-11-28 | 1992-06-03 | Ici Plc | Aryl derivatives |
| EP0501578A1 (en) * | 1991-02-28 | 1992-09-02 | Merck Frosst Canada Inc. | Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis |
| EP0501579A1 (en) * | 1991-02-28 | 1992-09-02 | Merck Frosst Canada Inc. | Naphthalene lactones as inhibitors of leukotriene biosynthesis |
| US5308852A (en) * | 1992-06-29 | 1994-05-03 | Merck Frosst Canada, Inc. | Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis |
-
1994
- 1994-04-07 AP APAP/P/1994/000632A patent/AP9400632A0/en unknown
- 1994-04-07 IL IL10925494A patent/IL109254A/en not_active IP Right Cessation
- 1994-04-13 CA CA002121199A patent/CA2121199C/en not_active Expired - Fee Related
- 1994-04-22 GB GB9408001A patent/GB9408001D0/en active Pending
- 1994-04-25 WO PCT/EP1994/001277 patent/WO1994025453A1/en active IP Right Grant
- 1994-04-25 CN CN94191925A patent/CN1052002C/zh not_active Expired - Fee Related
- 1994-04-25 CZ CZ952806A patent/CZ280695A3/cs unknown
- 1994-04-25 HU HU9502968A patent/HU9502968D0/hu unknown
- 1994-04-25 SK SK1349-95A patent/SK134995A3/sk unknown
- 1994-04-25 PL PL94311300A patent/PL311300A1/xx unknown
- 1994-04-25 AU AU67212/94A patent/AU681886B2/en not_active Ceased
- 1994-04-25 KR KR1019950704723A patent/KR100358464B1/ko not_active IP Right Cessation
- 1994-04-25 NZ NZ266139A patent/NZ266139A/xx not_active IP Right Cessation
- 1994-04-26 ES ES94303012T patent/ES2112483T3/es not_active Expired - Lifetime
- 1994-04-26 DK DK94303012T patent/DK0623614T3/da active
- 1994-04-26 JP JP08882694A patent/JP3553127B2/ja not_active Expired - Fee Related
- 1994-04-26 AT AT94303012T patent/ATE163417T1/de not_active IP Right Cessation
- 1994-04-26 EP EP94303012A patent/EP0623614B1/en not_active Expired - Lifetime
- 1994-04-26 DE DE69408593T patent/DE69408593T2/de not_active Expired - Fee Related
- 1994-04-28 US US08/234,148 patent/US5478842A/en not_active Expired - Lifetime
- 1994-04-30 TW TW083103922A patent/TW252978B/zh active
-
1995
- 1995-05-12 US US08/440,132 patent/US5512594A/en not_active Expired - Lifetime
- 1995-10-27 FI FI955165A patent/FI109123B/fi active
- 1995-10-27 NO NO954321A patent/NO309191B1/no not_active IP Right Cessation
-
1998
- 1998-05-05 HK HK98103836A patent/HK1004777A1/xx not_active IP Right Cessation
-
2002
- 2002-02-11 FI FI20020270A patent/FI20020270A/fi unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2294465A8 (en) | Perfluoroelastomeric compositions and methods | |
| GB9422158D0 (en) | N-acylindoles and related compounds | |
| HU9202842D0 (en) | Climotripsine-type proteases and inhibitors | |
| GB9518001D0 (en) | Container and its application | |
| HU9402884D0 (en) | 4-arylamino-benzopyran and related compounds | |
| EP0734398A4 (en) | COMPOUNDS AND METHODS | |
| HU9502968D0 (en) | 4-aryl-4-hydroxy-tetrahydropyrans and 3-aryl-3-hydroxy-tetrahydrofurans as 5-lipoxygenase inhibitors | |
| GB2281830B (en) | I/q-modulator and i/q-demodulator | |
| GB9420539D0 (en) | Process and composition | |
| GR3031378T3 (en) | Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors | |
| ZA939480B (en) | Enzyme inhibitor | |
| ZA946331B (en) | Pyran-4-ylmethyl-substituted arylalkylaryl- arylalkenylylaryl- and arylalkynylarylurea inhibitors of 5-lipoxygenase | |
| ZA945085B (en) | 5-Lipoxygenase inhibitors | |
| GB9501907D0 (en) | Allatostatins and their use | |
| GB9306456D0 (en) | Composition and use | |
| GB9308051D0 (en) | Method and composition | |
| ZA949525B (en) | Enzyme inhibitors | |
| GB9408859D0 (en) | Composition and use | |
| GB9302342D0 (en) | Compounds and methods | |
| GB9302343D0 (en) | Compounds and methods | |
| GB9319147D0 (en) | Compounds and methods | |
| GB9319149D0 (en) | Compounds and methods | |
| GB9319150D0 (en) | Compounds and methods | |
| GB9302361D0 (en) | Compounds and methods | |
| GB9325621D0 (en) | Compounds and methods |